Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) The impact of the IL-1β, IL-1Ra, IL-2, IL-6 and IL-10 gene polymorphisms on the...
Journal Information
Vol. 146. Issue 9.
Pages 379-383 (May 2016)
Share
Share
Download PDF
More article options
Visits
162
Vol. 146. Issue 9.
Pages 379-383 (May 2016)
Original article
The impact of the IL-1β, IL-1Ra, IL-2, IL-6 and IL-10 gene polymorphisms on the development of Behcet's disease and their association with the phenotype
Impacto de los polimorfismos genéticos de IL-1 beta, IL-1Ra, IL-2, IL-6 e IL-10 en el desarrollo de la enfermedad de Behcet y su asociación con el fenotipo
Visits
162
Savaş Barışa, Ömer Akyürekb,
Corresponding author
dromerakyurek@gmail.com

Corresponding author.
, Ahmet Dursunc, Mesut Akyold
a Department of Medical Genetics, Mevlana University Faculty of Medicine, Konya, Turkey
b Department of Internal Medicine, Mevlana University Faculty of Medicine, Konya, Turkey
c Department of Medical Genetics, Zonguldak Karaelmas University Medical Faculty Training and Research Hospital, Zonguldak, Turkey
d Department of Biostatistics, Yıldırım Beyazıt University, Ankara, Turkey
Related content
Med Clin. 2016;146:392-310.1016/j.medcle.2016.06.034
María Francisca González Escribano, Marco Antonio Montes Cano
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. The primary pairs used for the amplification of the investigated interleukins.
Table 2. Demographic and clinical characteristics of patient group.
Table 3. Comparison of polymorphic allele distribution.
Table 4. Comparison of polymorphic allele distribution in patient group for additional findings.
Show moreShow less
Abstract
Background and objective

This trial was designed to investigate the effects of the interleukin (IL)-1β, IL-1Ra, IL-2, IL-6, IL-10 gene polymorphisms on Behcet's disease (BD) occurrence and the association between the polymorphisms and the phenotype.

Materials and method

The study population consisted of 71 patients and 70 age and gender-matched healthy subjects. Each of the participants had 2cc of blood withdrawn, which was placed into a whole blood tube, and the DNA was obtained using the NucleoSpin® Blood DNA Isolation kit. To display the band lengths, the products were amplified using the primary pairs of the interleukins investigated and developed in a 2% agarose gel.

Results

There were no significant differences between the groups with respect to the IL-1Ra, IL-1β, IL-2, IL-6 and the IL-10 gene polymorphism distributions. In the patient group the IL-1RN2 gene polymorphism was detected to be statistically correlated with the presence of articular involvement (p=0.0283) and the IL-1β gene polymorphism was statistically correlated with the presence of an ocular lesion (p=0.0178). The evaluation of the IL-2 gene polymorphism (p=0.0065) and IL-10 gene polymorphism (p=0.0483) distributions with respect to age of BD onset revealed a statistically significant distribution.

Conclusion

The statistical correlations between the articular involvement and IL-1RN, the ocular involvement and the IL-1β, and the age of disease onset and the IL-2 and IL-10 gene polymorphisms, detected for the first time in the literature, suggest that these polymorphisms could be statistically associated with the disease symptoms and used as prognostic factors.

Keywords:
Behcet's disease
IL-1β
IL-1Ra
IL-2
IL-6 and IL-10
Resumen
Fundamento y objetivo

Este estudio fue designado para investigar los efectos de los polimorfismos genéticos de interleucina (IL)-1β, IL-1Ra, IL-2, IL-6 e IL-10 en la ocurrencia de la enfermedad de Behcet (EB) y la asociación entre los polimorfismos y el fenotipo.

Materials y método

La población de estudio consistió en 71 pacientes y 70 sujetos sanos emparejados por edad y sexo. A cada participante se le extrajeron 2cc de sangre y el ADN se obtuvo usando el kit NucleoSpin® Blood DNA Isolation. Para mostrar las longitudes de las bandas, los productos fueron amplificados usando los primeros pares de las IL investigadas y se desarrollaron en un gel de agarosa al 2%.

Resultados

No hubo diferencias significativas entre los grupos en relación con las distribuciones de los polimorfismos genéticos de IL-1Ra, IL-1β, IL-2, IL-6 e IL-10. En el grupo de pacientes, el polimorfismo genético de IL-1RN2 detectado se correlacionó estadísticamente con la presencia de afección articular (p=0,0283), y el polimorfismo genético de IL-1β se correlacionó estadísticamente con la presencia de lesión ocular (p=0,0178). La evaluación de la distribución del polimorfismo genético de IL-2 (p=0,0065) e IL-10 (p=0,0483) en relación con la edad de inicio de la EB reveló una distribución estadísticamente significativa.

Conclusión

La correlación estadística entre afección articular e IL-1RN, afección ocular e IL-1β, y la edad de inicio de la enfermedad y los polimorfismos genéticos de IL-2 e IL-10, detectados por primera vez en la literatura médica, evidencian que estos polimorfismos se asociaron estadísticamente a los síntomas de la enfermedad y se podrían usar como factores pronósticos.

Palabras clave:
Enfermedad de Behcet
IL-1β
IL-1Ra
IL-2
IL-6 e IL-10

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2022.08.009
No mostrar más